论文部分内容阅读
目的:探究分析临床中结核性胸膜炎的治疗情况,为了更好的治疗这一疾病作铺垫。方法:采用回顾性分析的方法,分析了我院在2013年1月1日至2013年12月31日间收治的120例患有结核性胸膜炎的患者的临床资料,采用抗结核化疗和抽取胸腔积液为主要方法,加以口服糖皮质激素作辅助治疗,观察患者治疗后的情况。结果:120例患者中,有68例达到痊愈,34例达到显效,13例达到有效,5例为无效,总有效率达95.8%,患者胸腔积液吸收的时间减少,症状缓解,5例治疗无效的病人在得到适当治疗后也得以好转,且没有长久的严重的不良反应出现。结论:采用联合抗结核化疗和抽取胸腔积液的方法,加以口服糖皮质激素作辅助治疗,可以有效治疗结核性胸膜炎。
Objective: To explore the clinical treatment of tuberculous pleurisy in order to better pave the way for the treatment of this disease. Methods: The clinical data of 120 patients with tuberculous pleurisy admitted in our hospital from January 1, 2013 to December 31, 2013 were retrospectively analyzed. The anti-TB chemotherapy and pleural extraction Fluid as the main method of oral corticosteroids for adjuvant therapy to observe the patient after treatment. Results: Among the 120 patients, 68 cases were cured, 34 cases achieved marked effect, 13 cases achieved effective, 5 cases were ineffective and the total effective rate was 95.8%. Patients’ time of pleural effusion absorption decreased, symptoms relieved, and 5 cases were treated Invalid patients also got better after getting proper treatment, and no long-term serious side effects occurred. Conclusion: The combination of anti-tuberculosis chemotherapy and pleural effusion extraction methods, oral glucocorticoid for adjuvant therapy, can effectively treat tuberculous pleurisy.